Another ETF company is making plans to move its ETFs to the NYSE Arca exchange (the NYSE has dictated the move for the ETF makers). XShares subsidiary HealthShares
, has received the approval of its board to begin the migration, expected to be completed prior to October 31, 2007. In September WisdomTree
was the first to announce that it would begin the migration of their ETFs to the Arca beginning today.
HealthShares(TM) Inc., an investment company with a family of 20 fund portfolios, today announced its Board of Directors has approved the transfer of its 19 currently NYSE-listed HealthShares exchange-traded funds (ETFs) to the NYSE Arca trading platform in accordance with NYSE Euronext requirement to transfer of all ETFs to the NYSE Arca LMM platform. The transfer is expected to be completed prior to October 31, 2007. The transfer is expected to be completed by October 26, 2007.
The ETFs scheduled to migrate to NYSE Arca include:
HealthShares Autoimmune-Inflammation ETF HHA
HealthShares Cancer ETF HHK
HealthShares Cardio Devices ETF HHE
HealthShares Cardiology ETF HRD
HealthShares Composite ETF HHQ
HealthShares Dermatology & Wound Care ETF HRW
HealthShares Diagnostics ETF HHD
HealthShares Emerging Cancer ETF HHJ
HealthShares Enabling Technologies ETF HHV
HealthShares European Drugs ETF HRJ
HealthShares European Medical Products & Devices ETF HHT
HealthShares GI/Gender Health ETF HHU
HealthShares Infectious Disease ETF HHG
HealthShares Metabolic-Endocrine Disorders ETF HHM
HealthShares Neuroscience ETF HHN
HealthShares Ophthalmology ETF HHZ
HealthShares Orthopedic Repair ETF HHP
HealthShares Patient Care Services ETF HHB
HealthShares Respiratory/Pulmonary ETF HHR
XShares Advisors LLC, a financial services company based in New York, is the creator of the HealthShares(TM) family of 20 Exchange Traded Funds (ETFs), of which 19 are currently trading. HealthShares(TM) ETFs are organized into therapeutic 'Verticals' and represent specific areas of the healthcare, life science and biotechnology industries. Each Vertical addresses a distinct sub-segment of healthcare, such as the diagnosis and treatment of specific therapeutic areas (e.g. cardiology, cancer, infectious disease, etc.) and the development of medical devices (e.g. orthopedic repair, cardio devices, etc.).
Each ETF tracks an index of 22-25 stocks and offers institutional and individual investors a more precise financial instrument that leverages the potential of healthcare investing while mitigating the risks of single stock picking. For more information, visit the company's website at www.healthsharesinc.com.
XShares Advisors LLC, a subsidiary of XShares Group LLC, is a registered investment advisor that provides investment advisory services to Exchange Traded Funds. XShares also partners with major institutions and index providers seeking to bring innovative Exchange Traded Funds to market using its administrative platform. In addition, XShares creates and licenses distinctive intellectual property for its ETFs, developing products that allow for innovative trading strategies and alternative investments for the financial community. For more information, visit the website at www.xsharesadvisors.com.
An Investor should consider the fund's investment objective, risks, charges and expenses carefully before investing. For this and more complete information about the fund call 800.925.2870 or visit the website www.healthsharesinc.com for a prospectus. Please read the prospectus carefully before investing.
There are risks involved with investing in ETFs including possible loss of money. HealthShares(TM) are not actively managed and are subject to risks similar to stocks, including those related to short selling and margin maintenance. Losses from short sales may be unlimited, and losses from purchases on margin may exceed original investment. HealthShares(TM) ETFs are subject to increased risks associated with investing in a specific sector compared to a more diversified investment, as well as unique risks associated with the healthcare and biotechnology sector (i.e., government regulation, patent regulation, etc.). The ETFs face additional risks attributable to their investments in small and medium capitalization companies which are subject to higher volatility than larger, more established companies. In addition, they are invested in a limited number of securities and a decline in the value of these investments would cause the fund's overall value to decline to a greater degree than in a less concentrated portfolio. Global or International Funds invest in foreign securities that will be subject to certain risks not associated with domestic securities, such as currency fluctuations, and changes in political and economic conditions. The prospectus is not an offer to buy or sell the portfolio shares, nor is the fund soliciting an offer to buy its shares in any jurisdiction where the offer or sale is not permitted.
HealthShares(TM) Exchange Traded Funds are distributed by ALPS Distributors, Inc.
Stay ahead of the news ... Sign up for our email alerts now